| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.038 | 0.5 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.039 | 0.5 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.5 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.034 | 0.5 |